心力衰竭患者长期血钾监测与动态变化及死亡风险
多变量校正后血钾与全因死亡呈U形关联,低钾血症和高钾血症的校正风险比分别为2.35和1.55,血钾正常化与较低死亡风险独立相关。
要点
- 心衰患者长期血钾水平与全因死亡呈U形关联,低钾和高钾均增加死亡风险。
- 低钾血症(<3.5 mEq/L)校正HR为2.35,高钾血症(>5 mEq/L)校正HR为1.55。
- 血钾恢复正常与较低死亡风险独立相关,持续异常者死亡风险更高。
核心结论
- 心衰患者长期监测中的血钾水平连续或分类均与全因死亡独立相关。
- 血钾持续异常者较维持或恢复正常者死亡风险更高。
研究设计与样本
- 前瞻性连续队列研究,纳入2164例既往急性心衰住院后出院患者。
- 采用可处理时间依赖暴露的多变量回归方法分析血钾与死亡关联。
主要发现
- 出院时平均血钾4.3±0.48 mEq/L;入院时低钾血症77例(3.6%)、正常血钾1965例(90.8%)、高钾血症122例(5.6%)。
- 中位随访2.8年(范围0.03-12.8年),1090例(50.4%)死亡。
- 连续血钾与死亡呈非线性U形关联(omnibus P=0.001)。
- 以正常血钾为参照,低钾血症校正HR 2.35(95%CI 1.40-3.93;P=0.001),高钾血症校正HR 1.55(95%CI 1.11-2.16;P=0.011)(omnibus P=0.0003)。
- 血钾动态变化与死亡风险独立相关,血钾正常化与较低死亡风险独立相关(P=0.001)。
临床怎么用
- 心衰患者应长期监测血钾,不限于住院期间。
- 对低钾血症和高钾血症均应积极纠正,使血钾维持在正常范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prognostic value of long-term potassium monitoring and dynamics in heart failure has not been characterized completely. We sought to determine the association between serum potassium values collected at follow-up with all-cause mortality in a prospective and consecutive cohort of patients discharged from a previous acute heart failure admission. METHODS: Serum potassium was measured at every physician-patient encounter, including hospital admissions and ambulatory settings. The multivariable-adjusted association of serum potassium with mortality was assessed by using comprehensive state-of-the-art regression methods that can accommodate time-dependent exposure modeling. RESULTS: The study sample included 2164 patients with a total of 16 116 potassium observations. Mean potassium at discharge was 4.3±0.48 mEq/L. Hypokalemia (<3.5 mEq/L), normokalemia (3.5-5.0 mEq/L), and hyperkalemia (>5 mEq/L) were observed at the index admission in 77 (3.6%), 1965 (90.8%), and 122 (5.6%) patients, respectively. At a median follow-up of 2.8 years (range, 0.03-12.8 years), 1090 patients died (50.4%). On a continuous scale, the multivariable-adjusted association of potassium values and mortality revealed a nonlinear association (U-shaped) with higher risk at both ends of its distribution (omnibus P=0.001). Likewise, the adjusted hazard ratios for hypokalemia and hyperkalemia, normokalemia as reference, were 2.35 (95% confidence interval, 1.40-3.93; P=0.001) and 1.55 (95% confidence interval, 1.11-2.16; P=0.011), respectively (omnibus P=0.0003). Furthermore, dynamic changes in potassium were independently associated with substantial differences in mortality risk. Potassium normalization was independently associated with lower mortality risk (P=0.001). CONCLUSIONS: Either modeled continuously or categorically, serum potassium levels during long-term monitoring were independently associated with mortality in patients with heart failure. Likewise, persistence of abnormal potassium levels was linked to a higher risk of death in comparison with patients who maintained or returned to normal values.
引用
- Núñez J, Bayés-Genís A, Zannad F, et al. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality. Circulation. 2017. PMID: 29025765. doi:10.1161/CIRCULATIONAHA.117.030576
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。